Accumulating evidence suggests a key role for AMPK in cancer initiation, by exerting tumor-suppressor functions, influencing inflammation, cell survival, and modulating cell-cycle arrest, and blocking the metabolic changes that take place during tumorigenesis [23,24,25,26,27]. Here, PRKAA2 is linked to neoplasm.